BOUL — Boule Diagnostics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK153.39m
- SEK357.49m
- SEK489.70m
Annual cashflow statement for Boule Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 36 | 29 | 39.3 | -350 | 20.8 |
| Depreciation | |||||
| Non-Cash Items | -2.03 | -4.11 | 29.6 | 392 | 10 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.2 | -63.4 | -17.5 | -18.9 | -30 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 43.3 | -11.4 | 51.4 | 46.6 | 0.8 |
| Capital Expenditures | -3.15 | -6.43 | -6.87 | -8.9 | -3.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -53.2 | -68.5 | -75.8 | -77 | -1.5 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -56.4 | -75 | -82.7 | -85.9 | -5 |
| Financing Cash Flow Items | -0.001 | -10.3 | -0.56 | 0 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.8 | 141 | -25.5 | 24.4 | 3.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.19 | 58.7 | -59.6 | -14.6 | -3.1 |